Skip to content

RxSight, Inc. RXST Gross Profit

Gross Profit at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$15.96B+9.8%
LENSAR, Inc. logo
LENSAR, Inc.LNSR
$6.38M-10.4%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$9.46M+0.2%
Precision Optics Corporation logo
Precision Optics CorporationPOCI
$2.06M+392%
Glaukos logo
GlaukosGKOS
$117.23M+42.4%

Other financials

Income statement

See full
Revenue$30.9M-18.5%
Operating income-$17.8M-67.0%
Net income-$15.9M-93.9%
EPS (diluted)-$0.38-90.0%

Balance sheet

See full
Cash & equivalents$17.6M-37.2%
Total debt$10.8M-10.1%
Total equity$267.3M-4.3%
Total assets$304.0M-2.9%

Cash flow

See full
Operating cash flow-$10.9M-23.3%
CapEx$759.0K+32.0%
Free cash flow-$11.7M-23.8%

Valuation

See full
Market cap$232.23M-56.8%
Enterprise value$225.49M-55.7%
P/S1.8×-1.8×

Profitability

See full
Gross margin77%+5.1pp
Operating margin-43.4%+128pp
Net margin-36.6%-867pp
FCF margin-16.9%+4.9pp

Returns & leverage

See full
Return on equity-17.1%+12.6pp
Debt / equity0.0×
Current ratio10.2×-2.5×

Where this comes from

Calculated from RxSight, Inc.’s reported figures.

The official record: RxSight, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about RxSight, Inc.'s gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is RxSight, Inc.'s gross profit?
RxSight, Inc. (RXST) reported gross profit of $23.5M in Q1 2026.
How has RxSight, Inc.'s gross profit changed year-over-year?
RxSight, Inc.'s gross profit decreased by 17.1% year-over-year, from $28.33M to $23.5M.
What is the long-term trend for RxSight, Inc.'s gross profit?
Over 4 years (2021 to 2025), RxSight, Inc.'s gross profit has grown at a 118.5% compound annual growth rate (CAGR), from $4.52M to $103.01M.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.